Policy Briefing

Policy Briefing

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

4 June 2026

Policy Briefing

FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head

18 May 2026

Policy Briefing

Trump Confirms Makary Exit; Diamantas Named Acting Chief

13 May 2026

Policy Briefing

Regeneron Closes MFN Deal; Offers Gene Therapy Free

27 April 2026

Policy Briefing

US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact

7 April 2026

Policy Briefing

The European Biotech Act, Explained

2 March 2026

Policy Briefing

Multistate Lawsuit Targets CDC Childhood Vaccine Rollback

25 February 2026

Policy Briefing

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

23 February 2026

Policy Briefing

FDA and EMA Issue Joint AI Principles for Drug Development

18 February 2026

Content

EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For

16 February 2026